Delveinsight

JULY 21, 2021

The prevalence is rising at a significant pace at par with heart disease and cancer and mounting a significant burden on the healthcare infrastructure and the degraded quality of life to the affected population. However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

XTalks

MAY 13, 2021

Novo Nordisk’s oral GLP-1 diabetes drug Rybelsus (semaglutide) has been up in the ranks this year in pharma TV ad spending, with the Danish pharma company having spent $19.9 The drug is a human glucagon-like peptide-1 (GLP-1) agonist that functions to increase insulin secretion from the pancreas. million and $18.6

Insulin 104

Insulin Marketing Branding Drugs 104

XTalks

AUGUST 17, 2020

Monoclonal antibodies : these are antibodies that are designed to bind to specific targets on cells. The design of the immune biologic puts these elements together on an antibody scaffold. With the Neo-STAT platform, “it’s like making a separate antibody molecule for each one of those. Immune system modulators (i.e.

Protein 98

Protein Engineer Immune Response In-Vivo 98